Why is Remus Pharma. falling/rising?

As of 30-Jun, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 1,970.35, which represents a decrease of 29.4 points or 1.47%. The stock has underperformed its sector by 2.16% today, despite having a higher performance than its 5-day and 20-day moving averages. However, it remains lower than the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a positive return of 9.57%, but it has declined by 5.66% over the past month and is down 21.11% year-to-date. There is a notable increase in investor participation, with delivery volume rising by 147.9% against the 5-day average, indicating some interest despite the overall negative trend.
In the broader market context, the Sensex has increased by 2.18% over the past week, contrasting with the stock's recent performance. While the stock has shown some short-term gains, its longer-term performance remains concerning, with a year-to-date decline of 21.11% compared to the Sensex's 7.92% increase. This suggests that while there may be short-lived interest in Remus Pharmaceuticals, the overall market sentiment and the stock's underperformance relative to the benchmark indicate a challenging environment for the company. The absence of specific positive or negative factors further complicates the outlook, leaving the reasons for the stock's decline somewhat unclear.